English Abstract
Evaluation Studies
Journal Article
Add like
Add dislike
Add to saved papers

[Prospective study of the Perigee system in the treatment of anterior pelvic organ prolapse].

OBJECTIVE: To evaluate the short-term efficacy of Perigee system in the treatment of anterior pelvic organ prolapse.

METHODS: From October 2012 to September 2014, 59 patients with pelvic organ prolapse, pelvic organ prolapse quantitation system (POP-Q) were diagnosed as anterior pelvic organ prolapse Ⅲ degree and above were performed Perigee anterior pelvic floor reconstruction, while some patients combined with sacrospinous ligament suspension, posterior wall repair or posterior pelvic reconstruction surgery for pelvic prolapses. Pelvic floor distress inventory-short form 20 (PFDI-20), pelvic organ prolapse-urinary incontinence sexual questionnaire-12 (PISQ-12) were evaluated, and postoperative POP-Q were used to analyze the changes of the indexes and postoperative complications.

RESULTS: In 59 patients, the average operation time was (99±29) minutes, the average intraoperative blood loss was (119± 92) ml. The median postoperative follow-up time of 59 cases was 17.5 months (range: 8-30 months), median follow-up time of subjuctive symptoms was 21.2 months (range: 11-34 months), the total score of PFDI-20 was compared with the preoperative, and the difference was statistically significant (5.6 versus 27.8,P< 0.01). It was statistically significant of PISQ-12 score before and after surgery (34±3 versus 36±4,P<0.05). Short-term anatomical cure rate was 98% (58/59), 1 cases (2%, 1/59) in recurrence, 2 cases (3%, 2/59) of erosion.

CONCLUSION: This results show that the Perigee system is effective and reliable in the treatment of anterior pelvic organ prolapse.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app